Evidence map›Paper›PMID 32576151›Full record

Trial reportBMC anesthesiology2020

Intravenous lidocaine to prevent endothelial dysfunction after major abdominal surgery: a randomized controlled pilot trial.

Marco Pustetto, Nicolas Goldsztejn, Karim Touihri, Edgard Engelman, Brigitte Ickx, Luc Van Obbergh

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC anesthesiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Marco PustettoDepartment of Anesthesiology, Centre Hospitalier Universitaire Grenoble-Alpes, Boulevard de la Chantourne, 38700, Grenoble, France. marco.pustetto@gmail.com.ORCID 0000-0002-8738-3280
Nicolas GoldsztejnDepartment of Anesthesiology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Karim TouihriDepartment of Anesthesiology, CHIREC Hospital group, Brussels, Belgium.
Edgard EngelmanDepartment of Anesthesiology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Brigitte IckxDepartment of Anesthesiology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Luc Van ObberghDepartment of Anesthesiology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Université Libre de Bruxelles · BECentre Hospitalier Interrégional Edith Cavell · BECentre Hospitalier Universitaire de Grenoble · FR

Funding

Conseil Médical Hopital Erasme 22-12-2016
6 · The paper itself

Abstract

backgroundMajor abdominal surgery is associated with endothelial glycocalyx disruption. The anti-inflammatory effects of lidocaine were recently associated with endothelial barrier protection.

methodsThis was a single-centre, parallel group, randomized, controlled, double blind, pilot trial. Forty adult patients scheduled for major abdominal surgery were included between December 2016 and March 2017 in the setting of a University Hospital in Brussels (Belgium); reasons for non-inclusion were planned liver resection and conditions associated to increased risk of local anesthetics systemic toxicity. Patients were randomized to receive either lidocaine by continuous intravenous administration or an equivalent volume of 0.9% saline. The primary endpoint was the postoperative syndecan-1 concentration (difference between groups). Near-infrared spectroscopy of the thenar eminence in association with the vascular occlusion test, and contemporary analysis of flow-mediated dilation of the brachial artery were the secondary outcomes, along with haemodynamic data. Blood samples and data were collected before surgery (T0), and at 1-3 h (T1) and 24 h (T2) post-surgery.

resultsSyndecan-1 concentration increased significantly post-surgery (P < 0.001), but without any difference between groups. The near-infrared spectroscopy-derived and flow-mediated dilation-derived variables showed minor changes unrelated to group assignment. Compared with the placebo group, the intervention group had a significantly lower peri-operative mean arterial pressure and cardiac index, despite equally conducted goal-directed haemodynamic management. Postoperative lactate concentrations were similar between groups.

conclusionsLidocaine failed to have any effect on endothelial function. Since in comparisons to other types of clinical situations, syndecan-1 was only slightly upregulated, endothelial dysfunction after major abdominal surgery might be overestimated.

trial registration« ISRCTN Registry » identifier: ISRCTN63417725. Date: 15/06/2020. Retrospectively registered.

Indexed as

AbdomenAdultAgedDouble-Blind MethodEndothelium, VascularFemaleHumansInfusions, IntravenousLidocaineMaleMiddle AgedPilot ProjectsPostoperative ComplicationsSyndecan-1LidocaineSDC1 protein, humanSyndecan-1Endothelial dysfunctionEndothelial glycocalyxLidocaineMajor abdominal surgery

Identifiers

PMID32576151
PMCPMC7310453
OpenAlexW3036009364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.